CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award | +2,032 | 72,661 | ||
| 2025-03-12 | Sheena Jonathan Director | Grant or award | +411 | 261,200 | ||
| 2025-03-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant or award | +2,893 | 2,415,415 | ||
| 2025-03-12 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +1,740 | 225,113 | ||
| 2025-03-12 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +2,040 | 145,808 | ||
| 2025-03-12 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +2,040 | 158,084 | ||
| 2025-03-12 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award | +6,702 | 210,056 | ||
| 2025-03-12 | Marcus Gail Boxer Director | Option exercise 10b5-1 | +4,000 | $7.86 | $31K | 13,704 |
| 2025-03-12 | Marcus Gail Boxer Director | Sale 10b5-1 | −1,014 | $145.86 | $148K | 12,690 |
| 2025-03-12 | Marcus Gail Boxer Director | Sale 10b5-1 | −923 | $147.20 | $136K | 11,767 |
| 2025-03-12 | Marcus Gail Boxer Director | Sale 10b5-1 | −1,682 | $148.71 | $250K | 10,085 |
| 2025-03-12 | Marcus Gail Boxer Director | Sale 10b5-1 | −381 | $149.27 | $57K | 9,704 |
| 2025-03-12 | Marcus Gail Boxer Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,000 | 1,130 | ||
| 2025-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,200 | $142.08 | $170K | 148,568 |
| 2025-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −2,700 | $143.05 | $386K | 145,868 |
| 2025-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,700 | $144.12 | $245K | 144,168 |
| 2025-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −400 | $144.97 | $58K | 143,768 |
| 2025-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −11,978 | $141.91 | $1.7M | 278,648 |
| 2025-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −30,298 | $142.79 | $4.3M | 248,350 |
| 2025-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −33,776 | $144.02 | $4.9M | 214,574 |
Page 53 of 55 · 1,093 trades